NovaBridge Biosciences.

IMAB · NASDAQ

$1.43+$0.125 (+9.62%)TodayMarket closed ·
Prev close $1.30

IMAB key statistics

Market cap
—
Price-earnings ratio
—
Dividend yield
—
Average volume
923.59K
Volume
615.09K
Open price
$1.30
High today
$1.46
Low today
$1.30
52 Week high
$6.79
52 Week low
$2.81

NovaBridge Biosciences. (IMAB) at a glance

NovaBridge Biosciences. (IMAB) last traded at $1.43.

Today the stock has traded between $1.30 and $1.46. The current price is 9.6% above the day's low and 2.4% below its high.

Volume so far is 615.09K shares, below the average of 923.59K shares a day.

Over the past year NovaBridge Biosciences. has ranged from $2.81 to $6.79, and now sits -35% of the way up that range.

The average analyst price target is $8.50, 496.5% above the current price, from 2 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 2 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 8 analystsAvg $8.50
Low
$7.07
Now
$1.43
High
$10.50

IMAB news

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of I-Mab - IMAB

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of I-Mab - IMAB

  • Press releasePRNewswire

    Cellular Immunotherapy Breakthroughs Fuel $370 Billion Market Surge

  • Press releasePRNewswire

    Novel Cancer Platforms Converge as Clinical Data Reshapes Treatment Paradigms

  • 12 Health Care Stocks Moving In Wednesday's Intraday Session

  • Press releaseGlobe Newswire

    I-Mab to Participate in September Investor Conferences

  • Press releasePRNewswire

    Everest Medicines Expands Strategic Investment in I-MAB

  • I-Mab to Join Virtual Biotech Event, Talks Cancer Treatment Progress With Investors

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.